Live Feeds
● LIVE Updated 43m ago · 20 sources tracked

Walmart settles US government's opioid lawsuit

Walmart agreed to pay $50 million to resolve a Department of Justice and Drug Enforcement Administration lawsuit alleging the company filled thousands of prescriptions for opioids and other controlled substances without legitimate medical purposes. The federal government claimed Walmart violated the Controlled Substances Act starting in June 2013. While Walmart pharmacists flagged suspicious orders and filed refusal-to-fill forms, prosecutors argued the company's compliance structure failed to act on those warnings. The settlement ends a legal battle that began with a 2020 federal filing regarding the failure to report suspicious orders.

RSS Source map (20)

What changed

Recent reports clarify the settlement resolves a lawsuit filed in 2020 and specifically addresses failures to respond to internal refusal-to-fill forms.

Live updates

  1. Walmart pays $50 million to settle federal opioid prescription lawsuit

    Walmart agreed to pay $50 million to resolve a Department of Justice and Drug Enforcement Administration lawsuit alleging the company filled thousands of prescriptions for opioids and other controlled substances without legitimate medical purposes. The federal government claimed Walmart violated the Controlled Substances Act starting in June 2013. While Walmart pharmacists flagged suspicious orders and filed refusal-to-fill forms, prosecutors argued the company's compliance structure failed to act on those warnings. The settlement ends a legal battle that began with a 2020 federal filing regarding the failure to report suspicious orders.

    Why it matters

    The case centers on the role of retail pharmacies in the broader opioid crisis. It highlights the tension between store-level pharmacist warnings and corporate compliance oversight. The resolution includes a new DEA framework for reporting and monitoring.

    What is confirmed

    • Walmart will pay $50 million to settle allegations from the Department of Justice and the Drug Enforcement Administration.
    • The settlement addresses alleged violations of the Controlled Substances Act dating from June 2013.
    • The lawsuit was filed in 2020.
    • Federal prosecutors alleged Walmart's compliance structure failed to respond to thousands of refusal-to-fill forms submitted by its own pharmacists.

    What to watch next

    • Implementation of the new DEA compliance framework
    • Potential similar settlements from other major retail pharmacy chains
    Sources used for this update (7)
    1. www.briefs.co — Italian Energy Firm Expands Venezuela Operations Amid US Push
    2. www.briefs.co — France Faces Budget Crisis as Political Gridlock Threatens Stability
    3. www.briefs.co — Russia Extends Diesel Export Ban as Ukrainian Refinery Strikes Continue
    4. www.ibtimes.co.uk — Walmart Agrees To Pay $50M in DOJ Settlement Over Alleged Opioid Prescriptions at Its Pharmacies
    5. www.financial-world.org — Walmart agrees to $50 million opioid prescription settlement
    6. www.aol.com — Walmart settles DOJ opioid crisis lawsuit for $50 million
    7. finance.yahoo.com — Walmart to pay $50m to settle DOJ opioid-dispensing allegations
    confidence 100%

  2. Walmart settles US government's opioid lawsuit for $50 million

    Walmart has agreed to pay $50 million to settle a US government lawsuit alleging its pharmacies filled thousands of invalid prescriptions for opioids and other controlled substances since 2013. The settlement includes a new DEA compliance framework with specific reporting and monitoring requirements. This resolves allegations from the Justice Department and DEA.

    Why it matters

    The lawsuit, filed in 2020, accused Walmart of fueling the nationwide opioid epidemic by unlawfully dispensing prescriptions from its pharmacies. The settlement removes a significant legal overhang for the company. Walmart is the nation's largest retailer.

    What is confirmed

    • Walmart will pay $50 million to settle the US government's opioid lawsuit.
    • The lawsuit alleged Walmart's pharmacies filled thousands of invalid prescriptions for opioids and other controlled substances since 2013.
    • The settlement includes a new DEA compliance framework with specific reporting and monitoring requirements.
    • The lawsuit was filed by the Justice Department and DEA in 2020.

    What to watch next

    • Walmart's implementation of the new DEA compliance framework
    • Potential impact on Walmart's operations and reputation
    • Any future lawsuits or actions related to opioid dispensing by Walmart
    Sources used for this update (5)
    1. www.businesstimes.com.sg — Walmart settles US government’s opioid lawsuit, which sought billions, for US$50 million
    2. www.yahoo.com — Walmart settles DOJ opioid crisis lawsuit for $50 million
    3. www.fox10phoenix.com — Walmart agrees to pay $50M settlement over allegations its pharmacies filled illegal opioid prescriptions
    4. www.texarkanagazette.com — Walmart settles U.S. government's opioid lawsuit, which sought billions, for $50 million
    5. www.devdiscourse.com — Reuters US Domestic News Summary
    confidence 100%

  3. Walmart settles federal lawsuit over opioid prescriptions

    Walmart has agreed to settle a U.S. government lawsuit regarding the unlawful dispensing of opioids and other controlled substances. The company will pay $50 million to resolve allegations from the Justice Department and DEA that its pharmacies filled thousands of invalid prescriptions since 2013. As part of the agreement, Walmart must adhere to a new DEA compliance framework that mandates specific reporting and monitoring requirements. The settlement removes a legal overhang that had affected the company since the Justice Department first filed the suit in 2020.

    Why it matters

    The Justice Department alleged that Walmart's pharmacy practices fueled the opioid epidemic by failing to properly monitor prescriptions. This federal action followed years of scrutiny over how major retail pharmacies handled controlled substances. The case specifically targeted practices dating back to 2013.

    What is confirmed

    • Walmart settled a U.S. government lawsuit regarding the unlawful dispensing of opioids.
    • The Justice Department sued Walmart in 2020.
    • The lawsuit alleged that Walmart pharmacies unlawfully dispensed opioids and controlled substances since 2013.
    • The settlement includes a new DEA compliance agreement with reporting and monitoring requirements.

    Still unconfirmed

    • Walmart is paying $50 million to resolve the DOJ and DEA allegations.
    • Walmart shares rose following the settlement.

    What to watch next

    • Details of the specific DEA reporting and monitoring requirements
    • Potential further legal actions from state governments regarding opioid dispensing
    Sources used for this update (10)
    1. Financial Times — Walmart settles lawsuit over painkiller prescriptions
    2. CNBC — Walmart settles U.S. government's opioid lawsuit
    3. CBS News — Walmart settles Justice Department lawsuit over unlawfully dispensing opioids
    4. qz.com — Walmart settles federal opioid lawsuit over pharmacy practices
    5. Yahoo Finance — Walmart settles US government's opioid lawsuit
    6. www.yahoo.com — Walmart settles federal opioid lawsuit over pharmacy practices
    7. journalrecord.com — Walmart settles federal lawsuit over role in opioid epidemic
    8. www.arise.tv — Walmart Settles US Government Lawsuit Over Alleged Opioid Violations
    9. dailyhodl.com — Walmart Is Paying $50,000,000 To Settle DOJ Claims Over Opioid Prescriptions Lawsuit
    10. finance.yahoo.com — Walmart Shares Rise After $Billion-Scale Opioid Lawsuit Settlement
    confidence 90%